Defining early-onset glaucomagenetic etiologies

(PI: Professor Janey Wiggs, Massachusetts Eye and Ear, Harvard Medical School)

Individuals who develop glaucoma before age 40 (early-onset glaucoma) have few treatment options and are most likely to become blind during their lifetimes. This NIH-funded project will use whole genome sequencing on 1500 individuals or family members affected by early-onset glaucoma, with the aim of revealing new genetic causes, improving risk prediction and genetic counselling, and identifying new and potentially curative therapeutic targets.

The Centre for Population Genomics is a joint national initiative of Garvan Institute of Medical Research and the Murdoch Children’s Research Institute. The Institutes are national leaders in genomic research, with complementary strengths spanning large-scale genomics, data science, population health, and clinical impact.

Back to Top

Privacy Policy

Careers

The Centre for Population Genomics values diversity in our team and our work. We believe that including all human diversity in genomic research will empower medical care that benefits everyone.

We pay our respect to all Aboriginal and Torres Strait Islander cultures and to their Elders past and present. We gratefully accept the invitation in the Uluru Statement from the Heart “to walk with us in a movement of the Australian people for a better future”.